Search

James Alan Wingrove

from Sunnyvale, CA
Age ~58

James Wingrove Phones & Addresses

  • 683 Erie Dr, Sunnyvale, CA 94087 (415) 350-4817
  • Ashland, OR
  • Mountain View, CA
  • San Francisco, CA
  • Laguna Niguel, CA
  • Daly City, CA
  • Julian, CA
  • Carlsbad, CA
  • San Diego, CA
  • Orange, CA
  • Santa Clara, CA
  • Santa Monica, CA

Work

Company: Dot laboratories, inc. May 2019 Position: Vice president research and development

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of California, Los Angeles Sep 1991 to Jun 1996 Specialities: Biochemistry

Skills

Genomics • Genetics • Biotechnology • Molecular Biology • Lifesciences • Life Sciences • Sequencing • Laboratory • Human Genetics • Science • Commercialization • Biochemistry • Hardware Diagnostics • Gene Expression • Oncology • Pharmaceutical Industry • Research and Development • Molecular Diagnostics • Molecular Genetics • Medical Diagnostics • Product Launch • Cross Functional Team Leadership • Biomarkers • Start Ups • Working With Physicians • Product Development • Assay Development • Immunology

Industries

Biotechnology

Resumes

Resumes

James Wingrove Photo 1

Vice President Research And Development

View page
Location:
683 Erie Dr, Sunnyvale, CA 94087
Industry:
Biotechnology
Work:
Dot Laboratories, Inc.
Vice President Research and Development

Cardiodx 2016 - Feb 2019
Vice President Technical Operations and Product Development

Cardiodx 2014 - 2016
Fellow, Head of Research

Cardiodx Apr 2010 - 2014
Senior Director of Research

Cardiodx Mar 2007 - Apr 2010
Director of Research
Education:
University of California, Los Angeles Sep 1991 - Jun 1996
Doctorates, Doctor of Philosophy, Biochemistry
University of San Diego Sep 1984 - Nov 1988
Bachelors, Bachelor of Arts, Biology
University of California, San Francisco
Skills:
Genomics
Genetics
Biotechnology
Molecular Biology
Lifesciences
Life Sciences
Sequencing
Laboratory
Human Genetics
Science
Commercialization
Biochemistry
Hardware Diagnostics
Gene Expression
Oncology
Pharmaceutical Industry
Research and Development
Molecular Diagnostics
Molecular Genetics
Medical Diagnostics
Product Launch
Cross Functional Team Leadership
Biomarkers
Start Ups
Working With Physicians
Product Development
Assay Development
Immunology

Publications

Wikipedia

Bush Christmas

View page

James Wingrove: Music by: The Bushwackers: Distributed by: Barron Films: Release date(s) 1983: Running time: 91 minutes: Country: Australia: Language: English

Us Patents

Predictive Models And Methods For Diagnosing And Assessing Coronary Artery Disease

View page
US Patent:
20110184712, Jul 28, 2011
Filed:
Oct 10, 2008
Appl. No.:
12/682579
Inventors:
Steve Rosenberg - Oakland CA, US
Susan Daniels - Mountain View CA, US
Michael R. Elashoff - Redwood City CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Amy J. Sehnert - San Francisco CA, US
Nicholas F. Paoni - Encinitas CA, US
Assignee:
CARDIODX, INC. - Palo Alto CA
International Classification:
G06G 7/60
US Classification:
703 11
Abstract:
Biomarkers useful for diagnosing and assessing the extent of coronary artery disease (CAD) are provided, along with kits for measuring their expression. The invention also provides predictive models, based on the biomarkers, as well as computer systems, and software embodiments of the models for scoring and optionally classifying samples. In a preferred embodiment, the biomarkers are organized into clustered groups. The expression level of the biomarkers within a group are highly correlated to each other in normal and disease states. Expression values of genes chosen from each of two, three, four or five of the clustered gene groups, A, B, C, D, E may be used. Alternatively, expression values of genes chosen from the groups are combined into a metagene. Preferred biomarkers include S100A12, S100A8, S100A9, BCL2A1, and F5 (group A); XK, P62, and FECH (group B); TUBB2 (group C); IFNG, PDGFB, VSIG4, and TNF (group D); CSF3R, TLR5, CD46, and NCF1 (group E); S100A12, S100A9, BCL2A1, TXN and CSTA (group I); OLIG1, OLIG2, ADORA3, CLC, and SLC29A1 (group II); and CBS and ARG1 (group IV).

Determining Susceptibility To A Sudden Cardiac Event

View page
US Patent:
20130013219, Jan 10, 2013
Filed:
Mar 18, 2011
Appl. No.:
13/635018
Inventors:
Steven Rosenberg - Oakland CA, US
Michael R. Elashoff - Redwood City CA, US
John Lincoln Blanchard - Redwood City CA, US
Susan Elizabeth Daniels - Mountain View CA, US
James Alan Wingrove - Sunnyvale CA, US
Amy Jo-Nell Sehnert - San Francisco CA, US
Assignee:
CARDIODX ,INC. - Palo Alto CA
International Classification:
G06F 19/10
C12Q 1/68
US Classification:
702 19, 435 611
Abstract:
Disclosed herein is a method of do terming the likelihood of a sudden cardiac event, such as an arrythmia, in a subject. Also disclosed is a method of determining whether a subject is at risk of a sudden cardiac event arid whether the subject would benefit from a treatment such as implantation of an ICD.

Determination Of Coronary Artery Disease Risk

View page
US Patent:
20110015865, Jan 20, 2011
Filed:
Jun 15, 2010
Appl. No.:
12/816232
Inventors:
Steven Rosenberg - Oakland CA, US
Michael R. Elashoff - Redwood City CA, US
Philip Beineke - Mountain View CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Susan E. Daniels - Mountain View CA, US
Assignee:
CARDIODX - Palo Alto CA
International Classification:
G06F 19/00
G01N 33/48
G06N 5/02
US Classification:
702 19, 706 52
Abstract:
Markers and methods useful for assessing coronary artery disease in a subject are provided, along with kits for measuring their expression. Also provided are predictive models, based on the markers, as well as computer systems, and software embodiments of the models for scoring and optionally classifying samples.

Markers For Coronary Artery Disease And Uses Thereof

View page
US Patent:
20180356432, Dec 13, 2018
Filed:
Aug 31, 2016
Appl. No.:
15/756430
Inventors:
- Redwood City CA, US
James A. WINGROVE - Sunnyvale CA, US
Karen FITCH - Mountain View CA, US
Steven ROSENBERG - Oakland CA, US
Andrea M. JOHNSON - Palo Alto CA, US
International Classification:
G01N 33/68
G06F 19/12
G16H 50/30
G16H 10/40
Abstract:
Markers and methods useful for assessing coronary artery disease in a subject are provided, along with related kits, systems, and media. Also provided are predictive models, based on the markers, as well as computer systems, and software embodiments of the models for scoring and optionally classifying samples.

Method For Determining Coronary Artery Disease Risk

View page
US Patent:
20150315652, Nov 5, 2015
Filed:
Jul 17, 2015
Appl. No.:
14/802544
Inventors:
- Redwood City CA, US
Michael R. Elashoff - Redwood City CA, US
Philip Beineke - Mountain View CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Susan E. Daniels - Mountain View CA, US
International Classification:
C12Q 1/68
G06F 19/00
G06F 19/20
Abstract:
Markers and methods useful for assessing coronary artery disease in a subject are provided, along with kits for measuring their expression. Also provided are predictive models, based on the markers, as well as computer systems, and software embodiments of the models for scoring and optionally classifying samples.

Methods And Compositions For Determining Smoking Status

View page
US Patent:
20150178462, Jun 25, 2015
Filed:
Aug 24, 2012
Appl. No.:
14/241156
Inventors:
Steven Rosenberg - Oakland CA, US
Michael Reid Elashoff - Redwood City CA, US
Phillip Beineke - Mountain View CA, US
James A. Wingrove - Sunnyvale CA, US
Assignee:
CardioDx, INC. - CA
International Classification:
G06F 19/00
C12Q 1/68
Abstract:
Peripheral blood markers are provided whose expression levels correlate with smoking status. Predictive models developed using highly informative markers are disclosed, along with systems, kits, and methods for using the markers to provide a biochemical surrogate for a subject's smoking status. In some embodiments, the smoking-related disease is chronic obstructive pulmonary disease, chronic bronchitis, emphysema, lung cancer, and/or asthma.

Determining Coronary Artery Disease Risk

View page
US Patent:
20140156198, Jun 5, 2014
Filed:
Jan 16, 2014
Appl. No.:
14/157196
Inventors:
- PALO ALTO CA, US
Michael R. Elashoff - Redwood City CA, US
Philip Beineke - Mountain View CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Susan E. Daniels - Mountain View CA, US
Assignee:
CARDIODX, INC. - PALO ALTO CA
International Classification:
G06F 19/00
US Classification:
702 19
Abstract:
Markers and methods useful for assessing coronary artery disease in a subject are provided, along with kits for measuring their expression. Also provided are predictive models, based on the markers, as well as computer systems, and software embodiments of the models for scoring and optionally classifying samples.
James Alan Wingrove from Sunnyvale, CA, age ~58 Get Report